IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bridgebio Pharma Inc

CUSIP: 10806XAJ1 | FRANKFURT | 53 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Wolverine Asset Management LLC97,940,000
1.0% of portfolio›$147.4M
Alberta Investment Management Corp30,000,000
0.3% of portfolio›$45.3M
Picton Mahoney Asset Management7,000,000
0.1% of portfolio›$10.6M
Advent Capital Management5,955,000
0.2% of portfolio›$9.0M
Citigroup Inc2,226,000
0.0% of portfolio›$3.4M
Universal- Beteiligungs- und Servicegesellschaft mbH1,270,000
0.0% of portfolio›$1.9M
Central Pacific Bank - Trust Division236,000
0.0% of portfolio›$355.4K
Calamos Advisors LLC191,000
0.0% of portfolio›$288.3K
Jefferies Financial Group Inc.24,000
0.0% of portfolio›$36.2K
StyleTurnoverLocationFiled
Wolverine Asset Management LLC
97,940,000$147.4M1.0%Deep ValueVery HighChicago, IL2026-11-02
Alberta Investment Management Corp
30,000,000$45.3M0.3%ValueHighEdmonton, Abu Dhabi2026-11-09
Picton Mahoney Asset Management
7,000,000$10.6M0.1%GARPHighToronto, Australia2026-11-09
Advent Capital Management
5,955,000$9.0M0.2%Deep ValueMediumNew York, NY2026-11-09
Citigroup Inc
2,226,000$3.4M0.0%CoreMediumNew York, NY2026-11-04
Universal- Beteiligungs- und Servicegesellschaft mbH
1,270,000$1.9M0.0%CoreLowFrankfurt Am Main, Hong Kong2026-11-10
Central Pacific Bank - Trust Division
236,000$355.4K0.0%CoreMediumHonolulu, HI2026-10-06
Calamos Advisors LLC
191,000$288.3K0.0%CoreMediumNaperville, IL2026-11-02
Jefferies Financial Group Inc.
24,000$36.2K0.0%CoreVery HighNew York, NY2026-11-05